Maxim Pharmaceuticals, Inc.
Records under this name other than patents Maxim Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Maxim Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,790,440 | Methods and compositions for promoting the maturation of monocytes Term ended Term ended Oct 9, 2021 · From the USPTO record | Term ended | Term ended Oct 9, 2021 | From the USPTO record |
| US 6,821,510 | Methods and compositions for promoting the maturation of monocytes Term ended Term ended Oct 9, 2021 · From the USPTO record | Term ended | Term ended Oct 9, 2021 | From the USPTO record |
| US 6,893,633 | Methods and compositions for promoting the maturation of monocytes Term ended Term ended Oct 9, 2021 · From the USPTO record | Term ended | Term ended Oct 9, 2021 | From the USPTO record |
| US 6,155,266 | Method for treatment of cancer and infectious disease Term ended Term ended Dec 21, 2019 · From the USPTO record | Term ended | Term ended Dec 21, 2019 | From the USPTO record |
| US 6,730,692 | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage Term ended Term ended Jan 8, 2019 · From the USPTO record | Term ended | Term ended Jan 8, 2019 | From the USPTO record |
| US 6,498,181 | Synergistic tumorcidal response induced by histamine Term ended Term ended Jan 6, 2019 · From the USPTO record | Term ended | Term ended Jan 6, 2019 | From the USPTO record |
| US 6,071,942 | Elevation of circulating blood histamine levels Term ended Term ended Nov 13, 2017 · From the USPTO record | Term ended | Term ended Nov 13, 2017 | From the USPTO record |
| US 6,063,373 | Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor Term ended Term ended Sep 17, 2017 · From the USPTO record | Term ended | Term ended Sep 17, 2017 | From the USPTO record |
| US 6,221,893 | Administration of histamine for therapeutic purposes Term ended Term ended Dec 16, 2016 · From the USPTO record | Term ended | Term ended Dec 16, 2016 | From the USPTO record |
| US 6,071,509 | Enhanced activation of natural killer cells using an NK cell activator and a hydrogen peroxide scavenger or inhibitor Term ended Term ended Jul 22, 2016 · From the USPTO record | Term ended | Term ended Jul 22, 2016 | From the USPTO record |